The transcriptional role of PML and the nuclear body
暂无分享,去创建一个
[1] N. Stuurman,et al. The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.
[2] R. Hay,et al. SUMO‐1 modification activates the transcriptional response of p53 , 1999, The EMBO journal.
[3] K. Umesono,et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.
[4] V. Ogryzko,et al. Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.
[5] G. Shaw,et al. Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System , 1999, Journal of Virology.
[6] R. Evans,et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein , 1994, Cell.
[7] A. Dejean,et al. Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.
[8] Maria Carmo-Fonseca,et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.
[9] M. Koken,et al. PML induces a novel caspase-independent death process , 1998, Nature Genetics.
[10] J. Larghero,et al. Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens , 1999, Leukemia.
[11] John Calvin Reed,et al. Human Daxx regulates Fas‐induced apoptosis from nuclear PML oncogenic domains (PODs) , 1999, The EMBO journal.
[12] A. Dejean,et al. PML nuclear bodies are general targets for inflammation and cell proliferation. , 1995, Cancer research.
[13] R. Tjian,et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation , 1999, Nature.
[14] L. Szekely,et al. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies , 1996, Journal of virology.
[15] P. Freemont,et al. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. , 1996, Oncogene.
[16] J. Hershey,et al. The Translation Initiation Factor eIF3-p48 Subunit Is Encoded byint-6, a Site of Frequent Integration by the Mouse Mammary Tumor Virus Genome* , 1997, The Journal of Biological Chemistry.
[17] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[18] T. Kouzarides,et al. Transcriptional repression by the promyelocytic leukemia protein, PML. , 1997, Experimental cell research.
[19] A. Dejean,et al. Viral Immediate-Early Proteins Abrogate the Modification by SUMO-1 of PML and Sp100 Proteins, Correlating with Nuclear Body Disruption , 1999, Journal of Virology.
[20] P. Freemont,et al. The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.
[21] A. Dejean,et al. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Pozzan,et al. Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival , 1998, Oncogene.
[23] Jennifer O'Neil,et al. Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML , 2000, Molecular and Cellular Biology.
[24] N. Ellis,et al. Molecular genetics of Bloom's syndrome. , 1996, Human molecular genetics.
[25] H. de Thé,et al. Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein , 1998, Journal of Virology.
[26] H. Will,et al. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. , 1992, Journal of immunology.
[27] P. Pandolfi,et al. Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.
[28] R. Evans,et al. Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Busch. The Cell Nucleus , 1966, Nature.
[30] Jonathan D. Licht,et al. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .
[31] P. Pandolfi,et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. , 1995, Oncogene.
[32] G. Blobel,et al. SUMO-1 Modification and Its Role in Targeting the Ran GTPase-activating Protein, RanGAP1, to the Nuclear Pore Complex , 1998, The Journal of cell biology.
[33] R. Everett,et al. A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.
[34] François-Michel Boisvert,et al. Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA , 2000, The Journal of cell biology.
[35] A. Hengstermann,et al. Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1 , 1999, The EMBO journal.
[36] A. Dejean,et al. Molecular Cloning of a New Interferon-induced PML Nuclear Body-associated Protein* , 1997, The Journal of Biological Chemistry.
[37] S. M. de la Monte,et al. Identification and Characterization of a Leukocyte-specific Component of the Nuclear Body* , 1996, The Journal of Biological Chemistry.
[38] Paul Tempst,et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex , 1999, Nature.
[39] J. Sobczak-Thépot,et al. The PML growth-suppressor has an altered expression in human oncogenesis. , 1995, Oncogene.
[40] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[41] J. Trowsdale,et al. A novel gysteine-rich sequence motif , 1991, Cell.
[42] Christine Chomienne,et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.
[43] M. King,et al. Insights into the functions of BRCA1 and BRCA2. , 2000, Trends in genetics : TIG.
[44] E. Lane,et al. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. , 1999, Experimental cell research.
[45] G. Lozano,et al. PML, a growth suppressor disrupted in acute promyelocytic leukemia , 1994, Molecular and cellular biology.
[46] E. Yeh,et al. Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific Protease* , 2000, The Journal of Biological Chemistry.
[47] P. Pandolfi,et al. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications , 1999, Oncogene.
[48] D. Levy,et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation , 1998, Nature.
[49] M. Ptashne,et al. Chromatin components as part of a putative transcriptional repressing complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Maul. Nuclear domain 10, the site of DNA virus transcription and replication , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[51] Y. Xiong,et al. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. , 1999, Molecular cell.
[52] T. Sternsdorf,et al. The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers* , 1999, The Journal of Biological Chemistry.
[53] E. Brignole,et al. Disruption of PML Subnuclear Domains by the Acidic IE1 Protein of Human Cytomegalovirus Is Mediated through Interaction with PML and May Modulate a RING Finger-Dependent Cryptic Transactivator Function of PML , 1998, Molecular and Cellular Biology.
[54] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[55] T. Kouzarides,et al. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein , 1998, Oncogene.
[56] M. Hochstrasser,et al. A new protease required for cell-cycle progression in yeast , 1999, Nature.
[57] P. Pandolfi,et al. Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications. , 1998, Leukemia & lymphoma.
[58] R. Everett,et al. A viral activator of gene expression functions via the ubiquitin–proteasome pathway , 1998, The EMBO journal.
[59] T. Sternsdorf,et al. Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1 , 1997, The Journal of cell biology.
[60] P. Pandolfi,et al. Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis , 2000, The Journal of experimental medicine.
[61] A. Dejean,et al. Viral Immediate-Early Proteins Abrogate the Modification by SUMO-1 of PML and Sp100 Proteins, Correlating with Nuclear Body Disruption , 1999, Journal of Virology.
[62] G. Maul,et al. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition , 1996, The Journal of cell biology.
[63] R. Everett,et al. The Ability of Herpes Simplex Virus Type 1 Immediate-Early Protein Vmw110 To Bind to a Ubiquitin-Specific Protease Contributes to Its Roles in the Activation of Gene Expression and Stimulation of Virus Replication , 1999, Journal of Virology.
[64] W. Zhang,et al. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[65] G. Hayward,et al. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells , 1997, Journal of virology.
[66] P. Pandolfi,et al. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins , 1999, Nature Genetics.
[67] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[68] T. Sternsdorf,et al. Nuclear dots: actors on many stages. , 1997, Immunobiology.
[69] N. Ellis,et al. The Bloom's syndrome gene product is homologous to RecQ helicases , 1995, Cell.
[70] P. Chambon,et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. , 1992, The EMBO journal.
[71] K. Borden,et al. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA , 2000, Oncogene.
[72] P. Chambon,et al. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. , 1993, The EMBO journal.
[73] R. Evans,et al. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] H. Saitoh,et al. Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.
[75] P. Pandolfi,et al. A role for PML and the nuclear body in genomic stability , 1999, Oncogene.
[76] Peirong Yang,et al. Analysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML(*) , 1996, The Journal of Biological Chemistry.
[77] E. Yeh,et al. Identification of Three Major Sentrinization Sites in PML* , 1998, The Journal of Biological Chemistry.
[78] J. Vonesch,et al. The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. , 1999, Journal of cell science.
[79] E. Yeh,et al. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.
[80] S. Orkin,et al. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[81] P. Pandolfi,et al. Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.
[82] R. Roeder,et al. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[83] K. Howe,et al. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. , 1998, American journal of human genetics.
[84] C. Ascoli,et al. Identification of a novel nuclear domain , 1991, The Journal of cell biology.
[85] P. Pelicci,et al. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. , 1991, Oncogene.
[86] L. Szekely,et al. The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein , 1998, Molecular and Cellular Biology.
[87] K. Chang,et al. The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter , 1998, Molecular and Cellular Biology.
[88] P. Freemont,et al. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. , 1991, Science.
[89] R. Jaenisch,et al. Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells. , 2000, Cancer research.
[90] K. Borden,et al. The promyelocytic leukemia protein PML has a pro‐apoptotic activity mediated through its RING domain , 1997, FEBS letters.
[91] R. Evans,et al. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[92] L. Szekely,et al. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. , 1996, Experimental cell research.
[93] E. Milgrom,et al. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. , 1995, Molecular endocrinology.
[94] A. Saïb,et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. , 1995, Oncogene.
[95] U. Scheer,et al. The nucleolus. , 1994, Current opinion in cell biology.